1. Introduction {#sec1-molecules-24-01393}
===============

Turmeric (*Curcuma longa* L., Zingiberaceae) is traditionally used in Indian medicine for the treatment of various illnesses, mainly connected with inflammatory processes. According to the Plant List database (<http://www.theplantlist.org>), the *Curcuma* genus includes more than 93 species, with different use and content of active substances. Turmeric is cultivated mainly in India, China, Indonesia, Jamaica, and Peru. The medicinal applications of turmeric have been known for thousands of years, especially by Ayurvedic therapy, which uses turmeric for stomach disorders, as a tonic, for blood cleansing, as well as for prevention or treatment of skin diseases. In addition, an administration of turmeric is recommended in disorders of bile production, anorexia, rhinitis, sinusitis, cough, diabetic lesions, disorders of liver functions, and rheumatism. The contemporary focus on turmeric and its substances can be tracked back to the 1970s, when mechanisms of its anti-inflammatory, antibacterial, and antioxidant properties started to be evaluated. However, readers should note that most of the scientific papers reporting the biological effects of curcumin represent preliminary in vitro data, obtained with biochemical (cell-free) assays or on cell culture models.

The aroma of turmeric is based on a bunch of sesquiterpenes. Typical examples are *(S)-ar*-turmerone, zingiberene, β-turmerone, and curlone. Their ratio and the presence of a wide range of other volatile compounds (e.g., monoterpenes) in various turmeric cultivars affect the aroma of curcuma when used as a food seasoning \[[@B1-molecules-24-01393]\]. The marker substances isolated from turmeric are called curcuminoids. The main representative of this group of compounds is the *bis*-α,β-unsaturated diketone curcumin (diferuloylmethane). Its structure had already been described by 1910. Curcumin is a compound showing keto-enol tautomerism, with the predominance of the keto form in acidic environment and stable enol form under basic conditions. Turmeric contains 2--5% of curcumin, according to the origin. After extraction, it is characterized as a yellow crystalline powder, practically insoluble in water, showing good solubility in fats and ethanol \[[@B2-molecules-24-01393]\].

Curcumin is famous for its potential applications in the prevention and treatment of cancer \[[@B3-molecules-24-01393]\], as well as for its anti-inflammatory, antioxidant \[[@B4-molecules-24-01393]\], and antiangiogenic activities \[[@B5-molecules-24-01393]\]. These activities were potentiated by the design and synthesis of structurally related analogues following a "lead optimization" approach. Meanwhile, curcumin may also inhibit β-amyloid formation and hence be potentially useful for preventing and treating Alzheimer's disease \[[@B6-molecules-24-01393],[@B7-molecules-24-01393],[@B8-molecules-24-01393],[@B9-molecules-24-01393],[@B10-molecules-24-01393]\]. There are several highly cited reviews that summarize the above-mentioned important research findings about the health beneficial effects of curcumin \[[@B11-molecules-24-01393],[@B12-molecules-24-01393]\]. Meanwhile, similar to those in other research fields, such as in nutritional neurosciences \[[@B13-molecules-24-01393],[@B14-molecules-24-01393],[@B15-molecules-24-01393],[@B16-molecules-24-01393]\], there have already been many meta-analyses of the effects of curcumin, including those with focus on downregulation of human tumor necrosis factor (TNF)-alpha levels \[[@B17-molecules-24-01393]\], alleviation of joint arthritis \[[@B18-molecules-24-01393]\], and regulation of blood lipid levels \[[@B19-molecules-24-01393]\]. With so many publications available in the existing literature, a bibliometric analysis could identify and quantitatively analyze the major themes of the curcumin research literature, as well as summarize the citation performance of various contributors and topics. Similar analyses have already been published in other research fields such as ethnopharmacology \[[@B20-molecules-24-01393]\], food sciences \[[@B21-molecules-24-01393]\], neuropharmacology \[[@B22-molecules-24-01393]\], nutraceuticals \[[@B23-molecules-24-01393]\], and oncology \[[@B24-molecules-24-01393]\].

The current study aimed to identify and analyze publications on curcumin to outline the major contributors in terms of author affiliations, countries/regions, and journals. It also aimed to reveal the major research themes present in the literature about curcumin, based on the publication and citation data. These pieces of information should be helpful for readers, including audience without deep previous knowledge of the topic, to quickly have a general overview of the curcumin literature landscape, including prominent authors, major output countries, and prevailing major research topics and trends. The provided information can also be used to identify potentially promising research directions and possible collaboration partners, and to give initial orientation to direct further more in-depth searches for the identification of relevant publications or research opportunities.

2. Materials and Methods {#sec2-molecules-24-01393}
========================

In November 2018, we accessed the Clarivate Analytics-owned Web of Science (WoS) Core Collection online database to identify curcumin publications with the following search string: TOPIC=("curcumin\*"). This search string identified publications that mentioned the word "curcumin" or its derivatives in the title, abstract, or keywords. We did not place additional restriction on the search strategy, such as publication year, publication type, or language. To gain insides into research focused on extracts of the plant *Curcuma longa*/turmeric, an additional analysis was performed to evaluate the publications that mentioned *Curcuma longa* or turmeric without mentioning curcumin, using the search strategy: TOPIC=("curcum\*" OR "tumeric\*" OR "turmeric\*" NOT "curcumin\*").

Data Extraction {#sec2dot1-molecules-24-01393}
---------------

The publications identified from the search were evaluated by: (1) publication year; (2) author affiliations; (3) countries/regions of the affiliations; (4) journal title; (5) WoS category; (6) publication type; (7) language; and (8) total citation count. The full records and cited references of these publications were downloaded and loaded into VOSviewer for further bibliometric analyses.

The VOSviewer software (v.1.6.8, 2018) is capable of extracting and analyzing the semantic contents of the titles, abstracts, and keywords of publications, relating them to the citation count data and generating a bubble map to visualize the results \[[@B25-molecules-24-01393]\]. Default parameters were used for the analyses and creation of bubble maps. The font size of the words in the bubble map indicates their frequency of occurrence (multiple appearances in a single publication count as one). Two words are nearer to each other if they co-occurred in the evaluated publications more frequently. Only words that appeared in at least 1.0% (*n* = 181) of the manuscripts were analyzed and visualized. For the keyword map, full counting method was used, meaning that each co-occurrence link carried the same weight. The default "association strength method" was used for normalization of the co-occurrence matrix with default values of attraction and repulsion.

We tested the possible correlation between total publication count and averaged citations per manuscript for the affiliations, countries/regions, and journals. For these data, we only considered entities that contributed to at least 0.01% (*n* = 19) of the publications. Pearson's correlation test was performed in SPSS 25.0 (IBM, New York, NY, USA). Test results with *p* \< 0.05 were considered statistically significant.

3. Results {#sec3-molecules-24-01393}
==========

The primary literature search resulted in 18,036 publications. The earliest articles on curcumin indexed in WoS were published in 1970 and 1971, and they investigated the hypocholesterolemic effect of curcumin in rats \[[@B26-molecules-24-01393],[@B27-molecules-24-01393]\]. More than half of the analyzed papers have been published since the year 2014. The large number of publications since 2014 could be attributed to the increased publication productivity of China (publications since 2014 = 2443; 68.9% of total contributions) and India (publications since 2014 = 1620; 51.8% of total contributions). The numbers of original articles (*n* = 14,315) and reviews (*n* = 1378) were in the ratio of 10.4:1. The majority of the publications were written in English (*n* = 17,871, 99.1%). Contributions came from 7729 organizations (author affiliations) located in 125 countries/territories and were published in 2905 journals. The top five WoS categories of the manuscripts were pharmacology and pharmacy (*n* = 3590, 19.9%), biochemistry and molecular biology (*n* = 2526, 14.0%), oncology (*n* = 1,894, 10.5%), multidisciplinary chemistry (*n* = 1485, 8.2%), and medicinal chemistry (*n* = 1469, 8.1%). The top five contributors with regard to journal, organization, and country/territory are listed in [Table 1](#molecules-24-01393-t001){ref-type="table"}. The five most productive countries were from Asia, except the United States.

There were 422 terms that appeared in at least 1.0% (*n* = 181) of the evaluated publications. By analyzing these words in the titles and abstracts of the 18,036 publications, we found that some notable highly cited themes of the publications were related to the effects of curcumin and its derivatives against cancer (*n* = 2583, citations per publication = 37.8), inflammation (*n* = 1210, citations per publication = 38.8), and oxidative stress (*n* = 1266, citations per publication = 29.6) ([Figure 1](#molecules-24-01393-f001){ref-type="fig"}). The top 20 recurring terms are listed in [Table 2](#molecules-24-01393-t002){ref-type="table"}.

Moreover, we examined the data to identify the prevalence of the use of metabolomics, proteomics, genomics, and transcriptomics, as well as clinical trials in curcumin research. "Metabolomic(s)" was mentioned in 42 publications, with a total of 293 citations. For example, it was found that, via nuclear magnetic resonance (NMR) spectroscopy-based metabolomics, in breast cancer cells the major target of curcumin was metabolism of glutathione \[[@B28-molecules-24-01393]\]. At the same time, "proteomic(s)" was mentioned in 62 publications, with a total of 526 citations. An example is a study showing that curcumin could bind to 197 proteins in HCT116 colon cancer cell line, which results in downregulation of cellular protein synthesis and induction of autophagy \[[@B29-molecules-24-01393]\]. Meanwhile, "genomic(s)" was mentioned in 77 publications, with a total of 1,691 citations. A representative study revealed that 1α,25-dihydroxyvitamin D(3) and curcuminoids had additive effects in stimulating amyloid clearance in patients of Alzheimer's disease \[[@B30-molecules-24-01393]\]. Similarly, the term "transcriptomic(s)" was mentioned in 20 publications, with a total of 244 citations. For instance, it was found that curcumin-treated lipopolysaccharide (LPS)-primed microglia showed limited neurotoxicity with the decrease of apoptosis \[[@B31-molecules-24-01393]\]. In terms of original articles with the term "clinical trial\*", there were 691 publications, with a total of 27,922 citations. Exemplars included Phase I clinical trial of oral curcumin (C3 complex) intake in patients with advanced colorectal cancer refractory to standard chemotherapies \[[@B32-molecules-24-01393]\]; and Phase II trial of oral curcumin intake in patients with advanced pancreatic cancer \[[@B33-molecules-24-01393]\].

Subsequently, we analyzed the keywords included into publications by authors and WoS (KeyWords Plus). As keywords are important for document searching and retrieval, authors usually carefully consider keyword selection for relevance, and a higher frequency of keywords use could indicate their importance. There were 108 keywords that appeared in at least 1.0% (*n* = 181) of the evaluated publications ([Figure 2](#molecules-24-01393-f002){ref-type="fig"}). In the bubble map presented as [Figure 2](#molecules-24-01393-f002){ref-type="fig"}, the size of the text/bubble is reflecting the frequency with which the keywords were used, and the color of the bubble is reflecting the citation frequency of the manuscripts in which the keywords were occurring. Therefore, a bigger size of the text/bubble might indicate a higher number of papers dealing with the respective topic, and a higher "intensity" of the color (according to the presented "color scale") reflects higher impact (more citations obtained) of the manuscripts. The major themes were similar as reported above ([Figure 1](#molecules-24-01393-f001){ref-type="fig"}) for the words in the titles and abstracts of the 18,036 publications. Here, as evident from [Figure 2](#molecules-24-01393-f002){ref-type="fig"}, we observed that several cancers were frequently mentioned, such as breast (*n* = 417, citations per publication = 26.4), colon (*n* = 208, citations per publication = 44.9), colorectal (*n* = 271, citations per publication = 40.1), pancreatic (*n* = 207, citations per publication = 33.2), and prostate (*n* = 276, citations per publication = 37.5) cancers. Frequently mentioned components for the potential mechanisms included nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB, *n* = 1558, citations per publication = 48.4), nitric oxide synthase (NOS, *n* = 275, citations per publication = 73.9), and TNF-α (*n* = 203, citations per publication = 38.7). Curcumin may inhibit tumor growth by inhibiting NF-κB activation \[[@B34-molecules-24-01393]\], and NOS \[[@B35-molecules-24-01393]\]. Meanwhile, Alzheimer's disease was also frequently mentioned (*n* = 746, citations per publication = 30.5). The top 20 recurring keywords are listed in [Table 3](#molecules-24-01393-t003){ref-type="table"}. The keywords suggested that many of the studies were in vitro or in vivo using (cancer) cells, rats, and mice, but not clinical studies in humans.

Chemicals that were frequently mentioned in the keywords of evaluated curcumin publications included, in descending order, curcuminoids (*n* = 475, citations per publication = 22.4), resveratrol (*n* = 344, citations per publication = 34.8), chitosan (*n* = 285, citations per publication = 10.9), flavonoids (*n* = 203, citations per publication = 42.6), quercetin (*n* = 197, citations per publication = 21.3), and polyphenols (*n* = 192, citations per publication = 36.8) ([Figure 3](#molecules-24-01393-f003){ref-type="fig"}). In particular, chitosan was outlined as a useful carrier to deliver curcumin to target cells or sites in the form of nanoparticles \[[@B36-molecules-24-01393],[@B37-molecules-24-01393]\].

To analyze the temporal changes in the use of keywords, we separated and assessed publications in four periods: 1989 and before, 1990s, 2000s, and 2010s. Unexpectedly, WoS did not record any keywords for the papers published in 1989 and before. The top 20 recurring keywords for each of the remaining three periods are listed in [Table 4](#molecules-24-01393-t004){ref-type="table"}. It could be observed that antioxidant effects and cancer remained popular throughout the three periods. Drug delivery, bioavailability, and nanoparticles were emerging keywords that became popular since the 2010s, implying that more attention has been given to improve the delivery of curcumin to target sites.

As over half of the publications were published since 2014, we further analyzed the top 20 keywords used in publications contributed by the top five countries/regions (China, India, the United States, Iran, and Italy) since 2014 ([Table 5](#molecules-24-01393-t005){ref-type="table"}). It seemed that the United States and Italy produced more curcumin-related manuscripts with relevance for Alzheimer's disease. Manuscripts from Iran and Italy more frequently referred curcumin-related placebo-controlled and randomized controlled trials. These five countries quite commonly shared the other top keywords.

Since research focused on extracts of the plant *Curcuma longa*/turmeric is highly relevant and closely related to curcumin-focused research, an additional analysis was performed to evaluate the publications that mentioned *Curcuma longa* or turmeric without mentioning curcumin. A search was done with the strategy: TOPIC=("curcum\*" OR "tumeric\*" OR "turmeric\*" NOT "curcumin\*"). We found 3920 publications resulting from this search. The most productive countries were India (*n* = 1041), China (*n* = 557), the United States (*n* = 388), Thailand (*n* = 286), and Japan (*n* = 265). The top five WoS categories were pharmacology and pharmacy (*n* = 720), food science technology (*n* = 561), plant sciences (*n* = 523), medicinal chemistry (*n* = 481), and integrative complementary medicine (*n* = 263). The top 20 keywords from these 3920 publications are listed in [Table 6](#molecules-24-01393-t006){ref-type="table"}. Keywords from these publications were more related to plant science studies, concerning the constituents and extracts, as well as the antimicrobial and antioxidant activity. As expected, there was some overlapping with the curcumin-focused publications, reflected by common keywords such as apoptosis, inhibition, and oxidative stress ([Figure 4](#molecules-24-01393-f004){ref-type="fig"}).

4. Discussion {#sec4-molecules-24-01393}
=============

The current study analyzed the curcumin literature with a bibliometric approach. The increased publication shares from Asian countries in recent years were similarly observed for antioxidants-related literature \[[@B4-molecules-24-01393]\]. Meanwhile, the huge contributions of the United States, China, and India were consistent with their dominance in ethnopharmacology research \[[@B20-molecules-24-01393]\]. According to a previous bibliometric study, Curcuma papers oriented to nutraceuticals and functional foods research fields received large contributions from the UK and European states \[[@B23-molecules-24-01393]\]. The unique geographic distribution here, different from bibliometric studies of other scientific disciplines, was the relatively large contribution from authors affiliated to Japanese and Korean institutions, especially on its biochemical and therapeutic properties, such as chemopreventive and anti-amyloidogenic effects \[[@B8-molecules-24-01393],[@B38-molecules-24-01393]\].

Because clinical trials comprised of a small proportion of the curcumin publications analyzed in the current study, the bubble maps did not show many terms indicative of clinical studies. This is unlike the situation in neuroscience, where bubble maps clearly showed two clusters of terms, with one cluster being more related to cellular, molecular, and genetic aspects, and the other one being more related to clinical aspects \[[@B39-molecules-24-01393]\].

By analyzing the studies describing clinical trial studies of curcumin, we found that oral curcumin (C3 complex) was a popular theme. Indeed, the C3 complex used in these studies is a standardized extract of dried rhizomes of *C. longa* and it represents the most clinically studied form of curcumin, evaluated in clinical trials in the context of cancer \[[@B32-molecules-24-01393],[@B33-molecules-24-01393]\], but also in multiple other conditions, including Alzheimer's disease \[[@B40-molecules-24-01393]\], psoriasis vulgaris \[[@B41-molecules-24-01393]\], oral lichen planus \[[@B42-molecules-24-01393]\], osteoarthritis \[[@B43-molecules-24-01393]\], inflammation associated with metabolic syndrome \[[@B44-molecules-24-01393]\] and obesity \[[@B45-molecules-24-01393]\], radiation dermatitis \[[@B46-molecules-24-01393]\], as well as for modulation of human gut microbiome \[[@B47-molecules-24-01393]\]. Moreover, while the low bioavailability of ingested curcumin had initially limited its clinical usage, a variety of different formulations with enhanced bioavailability have been recently developed and already studied in multiple clinical trials \[[@B48-molecules-24-01393],[@B49-molecules-24-01393],[@B50-molecules-24-01393]\].

We did not analyze the authorship of the curcumin publications. This was because there existed many Chinese authors who have similar initials that caused inaccurate counting. For instance, according to the data downloaded from WoS, the most prolific author for the evaluated curcumin publications was Li Y., which represented Li Yan, Li Yu, and Li Yiwei upon closer examination. Analyzing authorship by considering authors' full names was also not viable, because some publication records only listed author initials.

This study had some limitations, such as the use of a single database (WoS) to collect publications and their bibliometric data. Additionally, the analysis is of retrospective nature, and due to the fact that very recent trends (which still did not yield significant number of publications, due to their novelty) might remain undetected. Moreover, the readers should be reminded that articles mentioning *Curcuma longa* or turmeric/tumeric without mentioning curcumin were included in this work as a separate analysis, presented in [Table 6](#molecules-24-01393-t006){ref-type="table"} and [Figure 4](#molecules-24-01393-f004){ref-type="fig"}.

5. Conclusions {#sec5-molecules-24-01393}
==============

To conclude, a bibliometric analysis was performed to assess publications on curcumin research. Our findings have revealed that the United States and Asian countries, such as China, India, Japan, and South Korea, were major contributors. Most of the publications were focused on biochemistry, chemistry, oncology, and pharmacology. Over half of the publications were published since 2014, which mainly focused on the effects of curcumin against cancer, inflammation, and oxidative stress. Frequently investigated cancer types were breast, colon, colorectal, pancreatic, and prostate cancers. The large number of publications since 2014 could be attributed to the increased productivity of China (publications since 2014 = 2443; 68.9% of total contributions) and India (publications since 2014 = 1620; 51.8% of total contributions). Drug delivery, bioavailability, and nanoparticles have emerged as research themes for curcumin research. We expect that future studies should continue to improve delivery or even find new ways to deliver curcumin to target sites, so that more clinical studies can be supported.
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molecules-24-01393-t001_Table 1

###### 

The top five contributor journals, organizations, and countries/territories of the 18,036 manuscripts.

  Contributor                                              Publication Count (% of Total)   Citation Per Manuscript
  -------------------------------------------------------- -------------------------------- -------------------------
  *Journal*                                                                                 
  PLOS One                                                 234 (1.3%)                       21.6
  FASEB Journal                                            197 (1.1%)                       4.3
  Cancer Research                                          191 (1.1%)                       39.0
  RSC Advances                                             191 (1.1%)                       7.6
  Journal of Agricultural and Food Chemistry               187 (1.0%)                       41.2
  *Organization*                                                                            
  Council of Scientific Industrial Research (CSIR India)   503 (2.8%)                       12.1
  University of Texas                                      307 (1.7%)                       173.5
  University of California                                 239 (1.3%)                       71.1
  Wenzhou Medical University                               216 (1.2%)                       9.6
  Indian Institute of Technology                           200 (1.1%)                       20.2
  *Country/Territory*                                                                       
  United States                                            4073 (22.3%)                     39.0
  China                                                    3546 (19.7%)                     15.3
  India                                                    3128 (17.3%)                     23.4
  Japan                                                    990 (5.5%)                       28.7
  South Korea                                              884 (4.9%)                       24.3

Pearson's correlation tests revealed that there was a significant positive correlation between total publication count and averaged citations per manuscript for affiliations (r = 0.147, *p* = 0.005), but not for countries/regions (r = 0.131, *p* = 0.333), or journals (r = 0.032, *p* = 0.656). These results implied that the citation advantage by publishing more only existed in the affiliation level.

molecules-24-01393-t002_Table 2

###### 

The top 20 recurring terms from titles and abstracts.

  Term            Occurrence (% of 18,036 Publications)
  --------------- ---------------------------------------
  Curcumin        13,722 (76.1%)
  Effect          7958 (44.1%)
  Study           7418 (41.1%)
  Cell            6096 (33.8%)
  Activity        5832 (32.3%)
  Treatment       4917 (27.3%)
  Compound        3661 (20.3%)
  Level           3612 (20.0%)
  Expression      3363 (18.6%)
  Agent           3287 (18.2%)
  Mechanism       3087 (17.1%)
  Property        2939 (16.3%)
  Concentration   2858 (15.8%)
  Analysis        2735 (15.2%)
  Inhibition      2720 (15.1%)
  Pathway         2712 (15.0%)
  Drug            2663 (14.8%)
  Disease         2661 (14.8%)
  Group           2606 (14.4%)
  Protein         2597 (14.4%)

molecules-24-01393-t003_Table 3

###### 

The top 20 recurring keywords.

  Keyword               Occurrence (% of 18,036 Publications)
  --------------------- ---------------------------------------
  Curcumin              9539 (52.9%)
  Apoptosis             2223 (12.3%)
  In vitro              1909 (10.6%)
  Oxidative stress      1834 (10.2%)
  Nf kappa b            1558 (8.6%)
  Expression            1543 (8.6%)
  Cells                 1480 (8.2%)
  Cancer                1290 (7.2%)
  Inhibition            1269 (7.0%)
  Activation            1230 (6.8%)
  Antioxidant           1108 (6.1%)
  Nanoparticles         1021 (5.7%)
  Drug delivery         939 (5.2%)
  In vivo               880 (4.9%)
  Inflammation          808 (4.5%)
  Mice                  773 (4.3%)
  Cancer cells          768 (4.3%)
  Gene expression       768 (4.3%)
  Alzheimer's disease   746 (4.1%)
  Rats                  708 (3.9%)

molecules-24-01393-t004_Table 4

###### 

The top 20 recurring keywords in each decade.

  1990s                  Occurrence (% of 607)   2000s                Occurrence (% of 3683)   2010s              Occurrence (% of 13,636)
  ---------------------- ----------------------- -------------------- ------------------------ ------------------ --------------------------
  Curcumin               140 (23.1%)             Curcumin             1490 (40.5%)             Curcumin           7909 (58.0%)
  Inhibition             37 (6.1%)               Apoptosis            442 (12.0%)              Apoptosis          1773 (13.0%)
  Acid                   33 (5.4%)               Nf kappa b           383 (10.4%)              In vitro           1688 (12.4%)
  Tumor promotion        30 (4.9%)               Inhibition           355 (9.6%)               Oxidative stress   1538 (11.3%)
  Activation             28 (4.6%)               Expression           306 (8.3%)               Expression         1228 (9.0%)
  Chemoprevention        28 (4.6%)               Activation           298 (8.1%)               Cells              1188 (8.7%)
  Dietary curcumin       26 (4.3%)               Oxidative stress     291 (7.9%)               Cancer             1038 (7.6%)
  Mouse skin             24 (4.0%)               Cells                277 (7.5%)               Nanoparticles      1009 (7.4%)
  Cancer                 23 (3.8%)               Gene expression      267 (7.2%)               Nf kappa b         987 (7.2%)
  Antioxidants           22 (3.6%)               Cancer               229 (6.2%)               Activation         904 (6.6%)
  Curcuminoids           22 (3.6%)               Dietary curcumin     224 (6.1%)               Antioxidant        889 (6.5%)
  Lipid peroxidation     22 (3.6%)               In vitro             219 (5.9%)               Inhibition         877 (6.4%)
  Carcinogenesis         21 (3.5%)               Antioxidant          202 (5.5%)               Drug delivery      743 (5.4%)
  Turmeric               20 (3.3%)               Lipid peroxidation   172 (4.7%)               In vivo            740 (5.4%)
  Colon carcinogenesis   19 (3.1%)               Induction            147 (4.0%)               Inflammation       706 (5.2%)
  Induction              19 (3.1%)               In vivo              138 (3.7%)               Mice               644 (4.7%)
  In vitro               16 (2.6%)               Proliferation        133 (3.6%)               Bioavailability    610 (4.5%)
  Protein-kinase-c       16 (2.6%)               Curcuminoids         125 (3.4%)               Stability          609 (4.5%)
  Cells                  15 (2.5%)               Mice                 116 (3.1%)               Rats               588 (4.3%)
  Gene expression        14 (2.3%)               Chemoprevention      114 (3.1%)               Therapy            540 (4.0%)

molecules-24-01393-t005_Table 5

###### 

The top 20 recurring keywords, in descending order, used in the publications contributed by the top five most productive countries since 2014.

  \(1\) China        \(2\) India        \(3\) USA             \(4\) Iran                    \(5\) Italy
  ------------------ ------------------ --------------------- ----------------------------- -----------------------------
  Curcumin           Curcumin           Curcumin              Curcumin                      Curcumin
  Apoptosis          In vitro           In vitro              Oxidative stress              In vitro
  In vitro           Nanoparticles      Apoptosis             In vitro                      Oxidative stress
  Expression         Apoptosis          Nf kappa b            Cancer                        Nanoparticles
  Nanoparticles      Oxidative stress   Expression            Nanoparticles                 Nf kappa b
  Oxidative stress   Cancer             Oxidative stress      Apoptosis                     Apoptosis
  Cells              Drug delivery      Cancer                Cells                         Drug delivery
  Activation         Cells              Nanoparticles         Placebo-controlled trial      Inflammation
  Drug delivery      Antioxidant        Cells                 Drug delivery                 Cancer
  Inhibition         Bioavailability    In vivo               Antioxidant                   Expression
  Cancer             Delivery           Inflammation          Inhibition                    Alzheimer's disease
  Mice               Inhibition         Activation            Nf kappa b                    Cells
  Inflammation       Expression         Bioavailability       Randomized controlled trial   Randomized controlled trial
  Stability          Stability          Inhibition            Double-blind                  Placebo-controlled trial
  Proliferation      Derivatives        Drug delivery         Inflammation                  Polyphenols
  In vivo            Cytotoxicity       Delivery              Therapy                       Resveratrol
  Nf kappa b         Nf kappa b         Stability             Quality of life               Therapy
  Antioxidant        Design             Antioxidant           Delivery                      In vivo
  Delivery           Inflammation       Alzheimer's disease   Expression                    Double-blind
  Therapy            Formulation        Mice                  Mice                          Activation

molecules-24-01393-t006_Table 6

###### 

The top 20 recurring keywords from publications mentioning *C. longa* or turmeric but not curcumin.

  Keyword                  Occurrence (% of 3920 Publications)
  ------------------------ -------------------------------------
  Turmeric                 299 (7.6%)
  *Curcuma longa*          231 (5.9%)
  Essential oil            211 (5.4%)
  In vitro                 205 (5.2%)
  Zingiberaceae            198 (5.1%)
  Apoptosis                178 (4.5%)
  Antioxidant              176 (4.5%)
  Antioxidant activity     142 (3.6%)
  Constituents             140 (3.6%)
  Oxidative stress         131 (3.3%)
  Extract                  127 (3.2%)
  Expression               126 (3.2%)
  Antimicrobial activity   118 (3.0%)
  Cells                    114 (2.9%)
  Growth                   112 (2.9%)
  Curcuma                  110 (2.8%)
  Inhibition               110 (2.8%)
  Rats                     102 (2.6%)
  Sesquiterpenes           100 (2.6%)
  Ginger                   93 (2.4%)
